Neusoft Corp

Neusoft Corp's capital structure shows a market price of 8.53 CNY per share, with a market cap of 10.21 billion CNY. The company's price-to-book ratio is 1.13, and its price-to-tangible-book ratio is also 1.13, indicating a relatively modest premium over book value. The enterprise value to EBITDA ratio is negative at -33.90, reflecting the company's operating loss of 340.12 million CNY. The enterprise value to revenue ratio is 0.96, suggesting a relatively low valuation relative to revenue.

Profitability metrics show a return on equity of -3.97% and a return on assets of -1.92%, both significantly below the industry median for software companies. The company's gross profit margin is 20.5%, but this is offset by a negative operating margin of -2.83% and a net margin of -0.30%. These figures indicate that while the company maintains a reasonable gross margin, it is unable to convert this into positive operating or net profits.

Geographically, Neusoft Corp's revenue is primarily concentrated in China, with no disclosed international segments. The company's business is heavily dependent on the domestic market, which may expose it to regulatory and economic risks specific to the region. There are no disclosed segments or geographic breakdowns in the financial data, making it difficult to assess diversification.

The company's growth trajectory is mixed. Revenue for the latest period is 12.04 billion CNY, but the operating and net income are negative. Analysts have provided a mean price target of 10.71 CNY, suggesting a potential upside of 25.5% from the current market price. However, the company's free cash flow is negative at -484.12 million CNY, and capital expenditures are -222.73 million CNY, indicating ongoing investment in operations without immediate returns.

Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The debt-to-equity ratio is 0.15, suggesting a relatively low level of leverage, but the negative free cash flow and operating cash flow may limit the company's ability to service debt or invest in growth. The dilution risk is assessed as low, with no significant dilution potential in the near term.

Recent events include the latest financial filing, which shows a continued operating loss and negative net income. There are no recent transcripts or additional filings that provide further insight into the company's strategic direction or operational performance. The company's financial health remains a concern, with analysts providing a strong buy recommendation despite the negative earnings.